Rucha Patil on WFH Humanitarian Aid Program in India
Rucha Patil, Scientist, Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, shared a proud post on LinkedIn:
”The World Federation of Hemophilia Humanitarian Aid Department, in collaboration with Hemophilia Federation (India) organized a valuable workshop in Delhi, India, on 12-13 July 2025 focused on the effective use of Extended Half-Life (EHL) treatment products. The workshop aimed to enhance the utilization of EHL donations and provide training to treaters from recipient Hemophilia Treatment Centres (HTCs) across India.
We are proud to share that our KEM-ICMR-NIIH HTC been able to initiate low-dose Immune Tolerance Induction (ITI) using EHL products, thanks to the generous support from WFH and achieve a 60% success rate—an outcome we had the opportunity to present at this important workshop.
We are deeply grateful to WFH for their continued support and impactful donations. Their efforts are making a real difference in the lives of our patients.”
Stay updated on the latest news in the field of hemophilia with Hemostasis Today.
-
Jul 9, 2026, 13:54Hussein Yassine: Why Omega-3s May Fall Short in Preventing Alzheimer’s Disease
-
Jul 9, 2026, 13:16Olivier Mathieu: Innovating the Future of Hemostasis at ISTH 2026
-
Jul 9, 2026, 12:41Thomas Palmer-Dench: Hexokinase Controls Platelet Activation and Hemostasis
-
Jul 9, 2026, 12:19Paschalis Evangelidis: Join Our Special Issue on Thrombosis and Vascular Disorders
-
Jul 9, 2026, 12:16Fernanda Betti Solano: Could Iron Deficiency Be Affecting Your Sleep?
-
Jul 9, 2026, 12:08Andreas Calatzis: What is the Rationale for Collagen-Induced Platelet Aggregation Testing?
-
Jul 9, 2026, 11:54Deepak Pradhan։ Can Withaferin-A Help Combat Drug-Resistant Malaria?
-
Jul 9, 2026, 11:26Peter Zhang: Is Canada Ready for the Gene Therapy Era?
-
Jul 9, 2026, 09:35Pradeebha Muthukumar: Do You Know the Signs of Anemia?